4//SEC Filing
Apelian David 4
Accession 0001140361-23-033483
CIK 0001305253other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 5:37 PM ET
Size
5.1 KB
Accession
0001140361-23-033483
Insider Transaction Report
Form 4
Apelian David
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-07-03+750,000→ 750,000 totalExercise: $0.73Exp: 2033-07-02→ Common Stock (750,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over 48 months measured from July 3, 2023, subject to the Reporting Person's continuous service as of each such date.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001546842
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 5:37 PM ET
- Size
- 5.1 KB